Affinage

HSPB3

Heat shock protein beta-3 · UniProt Q12988

Length
150 aa
Mass
17.0 kDa
Annotated
2026-06-10
15 papers in source corpus 10 papers cited in narrative 10 extracted findings
Cross-family judge faithfulness: 5/5 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

HSPB3 is a muscle- and neuron-enriched small heat shock protein whose defining biochemical feature is obligate hetero-oligomerization with HSPB2 into a muscle-specific complex induced during MyoD-driven myogenic differentiation (PMID:10625651). Reconstitution from recombinant proteins establishes that HSPB2 and HSPB3 assemble in a strict 3:1 (HSPB2:HSPB3) ratio into species ranging from tetramers to 24-mers with low surface hydrophobicity and poor chaperone-like activity, and the crystal structure of the full-length hetero-tetramer shows four alpha-crystallin domains forming a flattened tetrahedron held together by IXI/V-motif and N-terminal contacts (PMID:19715703, PMID:29969581). On its own HSPB3 has target-dependent chaperone activity that is constrained by its unusually short C-terminal extension (PMID:22610661), and incorporation into the HSPB2/B3 complex restricts its interaction repertoire so that it does not associate with HSP20, HSP27, or alphaB-crystallin (PMID:19715703, PMID:16225851); HSPB3 also negatively regulates HSPB2 binding to the co-chaperone BAG3 (PMID:28181153). Beyond chaperoning, HSPB3 has a distinct nuclear function: it binds the lamin B receptor (LBR) and keeps it dynamic, and HSPB3 is both required and sufficient to drive myogenic gene transcription and differentiation, with the disease mutant R116P forming nuclear aggregates that immobilize LBR, trigger the unfolded protein response, and block differentiation (PMID:33958580). In motor neurons HSPB3 supports neuronal survival (PMID:27567740), and a disease-associated Y118H mutant causes mitochondrial dysfunction and impaired mitophagy that is rescued by PINK1/Parkin, placing HSPB3 within the PINK1-Parkin mitophagy axis (PMID:37804589).

Mechanistic history

Synthesis pass · year-by-year structured walk · 8 steps
  1. 2000 High

    Established that HSPB3 is not a free-standing sHSP but a partner of HSPB2 in a muscle-specific complex that is induced during differentiation, distinguishing it from the canonical sHSP network.

    Evidence Co-IP, gel filtration, tissue distribution, and myogenic differentiation assays in myotubes

    PMID:10625651

    Open questions at the time
    • Subunit stoichiometry of the complex not yet resolved
    • Functional consequence of the HSPB2/B3 complex unknown
    • Did not test chaperone activity directly
  2. 2009 High

    Defined the precise architecture and biochemical character of the complex, showing a fixed 3:1 stoichiometry and explaining its poor chaperone activity via low surface hydrophobicity and a restricted interaction repertoire.

    Evidence Native mass spectrometry, analytical ultracentrifugation, CD, ANS hydrophobicity, Co-IP, and in vitro chaperone assays on recombinant proteins

    PMID:19715703

    Open questions at the time
    • No physiological substrate identified
    • Functional role of the complex in cells not addressed
    • Atomic structure not yet determined
  3. 2012 High

    Showed that HSPB3 alone has intrinsic, target-selective chaperone activity and that its short C-terminal extension is the structural determinant restricting its substrate range.

    Evidence Gel filtration, AUC, CD, multi-substrate aggregation assays, and C-terminal chimera engineering with recombinant HspB3

    PMID:22610661

    Open questions at the time
    • In vitro substrates may not reflect physiological clients
    • Behavior of free HSPB3 versus complexed HSPB3 in cells unclear
  4. 2018 High

    Provided an atomic-resolution explanation of how the 3:1 hetero-tetramer assembles, revealing IXI/V-motif and N-terminal contacts and unexpected plasticity in terminal-region interactions.

    Evidence X-ray crystallography of the full-length human HspB2/B3 hetero-tetramer

    PMID:29969581

    Open questions at the time
    • Structures of larger oligomeric species not resolved
    • Structural basis of disease mutations not addressed
    • Does not explain client recognition
  5. 2017 Medium

    Placed HSPB3 within the sHSP/co-chaperone regulatory network by showing it modulates HSPB2-BAG3 association, distinguishing its complex from the BAG3-dependent HSPB8 pathway.

    Evidence Co-IP in overexpression and endogenous human myoblast contexts

    PMID:28181153

    Open questions at the time
    • Single lab, no in vitro reconstitution
    • Functional consequence of altered HSPB2-BAG3 binding not measured
    • Mechanism of negative regulation unknown
  6. 2021 High

    Uncovered a chaperone-independent nuclear function: HSPB3 binds LBR and keeps it dynamic to drive myogenic transcription, and demonstrated that a disease mutant immobilizes LBR and blocks differentiation.

    Evidence Reciprocal Co-IP, FRAP, siRNA knockdown, overexpression in human muscle cell lines, and disease-mutant validation

    PMID:33958580

    Open questions at the time
    • Mechanism linking LBR dynamics to transcription not defined
    • Whether the HSPB2/B3 complex or free HSPB3 mediates this is unclear
    • Single lab
  7. 2016 Medium

    Demonstrated a neuronal role by showing HSPB3 is expressed in motoneurons and that wild-type, but not mutant, HSPB3 promotes motoneuron survival.

    Evidence In ovo overexpression in an avian motoneuron degeneration model with survival counts and immunohistochemistry

    PMID:27567740

    Open questions at the time
    • Molecular mechanism of survival benefit not defined
    • Single in vivo assay system
    • Endogenous loss-of-function not tested
  8. 2023 Medium

    Linked the neuronal HSPB3 disease mutant to mitochondrial quality control, showing Y118H impairs mitophagy and is rescued by PINK1/Parkin, placing HSPB3 in the PINK1-Parkin axis.

    Evidence Drosophila transgenic models with motor assays, mitochondrial membrane potential, mitophagy reporters, and PINK1/Parkin genetic epistasis

    PMID:37804589

    Open questions at the time
    • Direct molecular target of HSPB3 in the mitophagy pathway unknown
    • Single lab, first animal model for this mutation
    • Whether effect is conserved in mammalian motor neurons untested

Open questions

Synthesis pass · forward-looking unresolved questions
  • How HSPB3's distinct activities — chaperoning within the HSPB2/B3 complex, nuclear LBR regulation of transcription, and support of mitochondrial quality control in neurons — are mechanistically connected, and how disease mutations disrupt each, remains unresolved.
  • No unified mechanism linking nuclear and mitochondrial functions
  • Physiological client proteins of the chaperone activity unidentified
  • Structural basis of pathogenic mutations not determined

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0044183 protein folding chaperone 2 GO:0098772 molecular function regulator activity 1 GO:0140110 transcription regulator activity 1
Localization
GO:0005634 nucleus 1 GO:0005654 nucleoplasm 1 GO:0005829 cytosol 1
Pathway
R-HSA-1266738 Developmental Biology 2 R-HSA-392499 Metabolism of proteins 2 R-HSA-9612973 Autophagy 1
Partners
BAG3HSPB2LBR
Complex memberships
HSPB2/HSPB3 hetero-oligomer

Evidence

Reading pass · 10 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2000 HSPB3 and HSPB2/MKBP form a muscle-specific oligomeric complex (~150 kDa) that is completely independent of oligomers formed by HSP27, alphaB-crystallin, and p20. Expression of both HSPB2 and HSPB3 is induced during myogenic differentiation under control of MyoD. Unlike HSPB2, HSPB3 does not interact with myotonic dystrophy protein kinase, and neither HSPB2 nor HSPB3 associates with actin bundles in myotubes. Co-immunoprecipitation, gel filtration, tissue distribution analysis, immunofluorescence localization in myotubes, myogenic differentiation assays The Journal of biological chemistry High 10625651
2009 Recombinant HSPB2 and HSPB3 form well-defined hetero-oligomers (tetramers to 24-mers) with a strict 3:1 HSPB2:HSPB3 subunit ratio. The HSPB2/B3 complex shows poor chaperone-like and thermoprotective activity correlated with low surface hydrophobicity. When HSPB3 is complexed with HSPB2, the resulting oligomer cannot interact with HSP20, HSP27, or alphaB-crystallin, whereas homomeric HSPB2 (not in complex with HSPB3) can associate with HSP20. Nanoelectrospray ionization mass spectrometry, sedimentation velocity analytical ultracentrifugation, far-UV circular dichroism spectroscopy, ANS hydrophobicity assay, co-immunoprecipitation, in vitro chaperone activity assays Journal of molecular biology High 19715703
2012 Recombinant human HspB3 forms polydisperse oligomers with predominantly trimeric species, exhibits beta-sheet secondary structure, and has molecular chaperone-like activity preventing heat-induced aggregation of ADH and citrate synthase but does NOT prevent DTT-induced aggregation of insulin, demonstrating target protein-dependent chaperone activity. Fusion of the alphaB-crystallin C-terminal extension to HspB3 alters its quaternary structure and increases chaperone activity toward insulin, revealing that the short C-terminal extension of HspB3 restricts its substrate range. Gel filtration, sedimentation velocity analytical ultracentrifugation, circular dichroism, in vitro chaperone aggregation assays (ADH, citrate synthase, insulin), chimeric protein engineering Cell biochemistry and biophysics High 22610661
2018 Crystal structure of full-length human HspB2/HspB3 hetero-tetramer (3:1 ratio) shows four alpha-crystallin domains assembling into a flattened tetrahedron. Assembly is mediated by IXI/V motifs from terminal regions filling ACD pockets, and parts of the N-terminal region bind in an unfolded conformation into anti-parallel shared ACD dimer grooves, revealing a plasticity in terminal-region interactions. X-ray crystallography of full-length human HspB2/B3 hetero-tetramer Journal of molecular biology High 29969581
2005 HSP22/HSPB8 interacts with alphaB-crystallin and HSP20 but does NOT interact detectably with HSPB3 by yeast two-hybrid or FRET; HSPB3 is found in high-molecular-weight HPLC fractions of primate cardiac muscle together with alphaB-crystallin and HSP20, consistent with its participation in large complexes. Yeast two-hybrid assay, FRET microscopy, HPLC fractionation of cardiac muscle extracts Biochemical and biophysical research communications Medium 16225851
2017 In mammalian cells, HSPB3 negatively regulates the interaction of HSPB2 with the co-chaperone BAG3: overexpression of HSPB3 reduces HSPB2-BAG3 association, whereas in human myoblasts expressing endogenous HSPB2, HSPB3, HSPB8, and BAG3, BAG3 interacts selectively with HSPB8 and not with HSPB2 or HSPB3. Co-immunoprecipitation in mammalian (overexpression) and human myoblast (endogenous) cells Cell stress & chaperones Medium 28181153
2021 HSPB3 binds to the lamin B receptor (LBR) in the nucleoplasm and maintains LBR in a dynamic state, promoting transcription of myogenic genes including extracellular matrix remodeling genes. Depletion of HSPB3 prevents myoblast differentiation. Overexpression of HSPB3 alone is sufficient to induce differentiation of LHCNM2 and rhabdomyosarcoma cells. The disease-associated mutant R116P-HSPB3 forms nuclear aggregates that immobilize LBR and activates the unfolded protein response, failing to induce differentiation. Co-immunoprecipitation (HSPB3-LBR), FRAP (LBR dynamics), siRNA knockdown, HSPB3 overexpression in human muscle cell lines, immunofluorescence, gene expression analysis Cell death & disease High 33958580
2016 HSPB3 protein is expressed in motoneurons in vivo (spinal cord of chicken, mouse, and human). Overexpression of wild-type HSPB3 in an avian limb-bud removal model of motoneuron degeneration promotes motoneuron survival, while mutant HSPB3 does not provide the same survival benefit. In ovo overexpression in avian motoneuron degeneration model, immunohistochemistry for endogenous localization, motoneuron survival counts Experimental neurology Medium 27567740
2023 The disease-associated HSPB3 Y118H mutant induces loss of motor activity and reduces mitochondrial membrane potential in Drosophila neuronal tissues. Mitophagy is downregulated in fly motor neurons expressing HSPB3 Y118H. Overexpression of PINK1 and Parkin (core mitophagy regulators) rescues both motor and mitochondrial defects caused by the mutant, placing HSPB3 function upstream of or within the PINK1-Parkin mitophagy pathway in neurons. Drosophila transgenic overexpression, motor activity assays, mitochondrial membrane potential measurement, mitophagy reporter assays, genetic epistasis with PINK1/Parkin Biochemical and biophysical research communications Medium 37804589
1998 HspB3 cDNA encodes a 150-amino-acid polypeptide; among six known human sHSPs it is the most divergent, with a unique N-terminal domain and essentially no C-terminal extension. Northern blot shows expression primarily in smooth muscle tissue. cDNA sequence analysis, Northern blot Biochimica et biophysica acta Low 9858786

Source papers

Stage 0 corpus · 15 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2000 Muscle develops a specific form of small heat shock protein complex composed of MKBP/HSPB2 and HSPB3 during myogenic differentiation. The Journal of biological chemistry 247 10625651
2005 Interactions of HSP22 (HSPB8) with HSP20, alphaB-crystallin, and HSPB3. Biochemical and biophysical research communications 75 16225851
1998 HspB3, the most deviating of the six known human small heat shock proteins. Biochimica et biophysica acta 50 9858786
2009 The small heat-shock proteins HSPB2 and HSPB3 form well-defined heterooligomers in a unique 3 to 1 subunit ratio. Journal of molecular biology 45 19715703
2018 Terminal Regions Confer Plasticity to the Tetrameric Assembly of Human HspB2 and HspB3. Journal of molecular biology 38 29969581
1996 Isolation and characterization of a human heart cDNA encoding a new member of the small heat shock protein family--HSPL27. Biochimica et biophysica acta 23 8972725
2012 Structural aspects and chaperone activity of human HspB3: role of the "C-terminal extension". Cell biochemistry and biophysics 22 22610661
2021 Small heat-shock protein HSPB3 promotes myogenesis by regulating the lamin B receptor. Cell death & disease 20 33958580
2019 Heat shock protein beta 3 (HSPB3) is an unfavorable molecular biomarker in colorectal adenocarcinoma. Molecular carcinogenesis 20 31709619
2016 HSPB3 protein is expressed in motoneurons and induces their survival after lesion-induced degeneration. Experimental neurology 20 27567740
2017 An interaction study in mammalian cells demonstrates weak binding of HSPB2 to BAG3, which is regulated by HSPB3 and abrogated by HSPB8. Cell stress & chaperones 19 28181153
2018 Small heat shock protein B3 (HSPB3) mutation in an axonal Charcot-Marie-Tooth disease family. Journal of the peripheral nervous system : JPNS 13 29341343
2010 Map3k1, Il6st, Gzmk, and Hspb3 gene coexpression network in the mechanism of freezing reaction in mice. Journal of neuroscience research 7 21162133
2022 Human HspB1, HspB3, HspB5 and HspB8: Shaping these disease factors during vertebrate evolution. Cell stress & chaperones 6 35678958
2023 PINK1 and Parkin rescue motor defects and mitochondria dysfunction induced by a patient-derived HSPB3 mutant in Drosophila models. Biochemical and biophysical research communications 1 37804589

Missed literature

Know a paper Affinage missed for HSPB3? Flag it for the maintainers and the community.

No submissions yet.